Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model

By Menu Eline   Leenheer Evy   Raeve Hendrik   Coulton Les   Imanishi Takeshi   Miyashita Kazuyuki   Valckenborgh Els   Riet Ivan   Camp Ben   Horuk Richard   Croucher Peter   Vanderkerken Karin  

Clinical and Experimental Metastasis, Vol. 23, Iss. 5-6, 2006-11 ,pp. : 291-300

Springer Publishing Company

Access to resources Recommend Favorite

TRAIL produced from multiple myeloma cells is associated with osteolytic markers

By                  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 39-44

Spandidos Publications

Access to resources Recommend Favorite

Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement

By Capalbo Silvana   Chiefa Antonia   Delia Mario   Diomede Daniela   Liso Vincenzo  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 262-264

Informa Healthcare

Access to resources Recommend Favorite

Loss of histidine decarboxylase as a marker of malignant transformation and dedifferentiation of B-cells infiltrating the skin. A case report of a therapy-resistant multiple myeloma complicated by skin infiltration

By Varkonyi Judit   Karadi Istvan   Szőcs Katalin   Sugar Istvan   Sapi Zoltan   Marschalko Marta   Pallinger Eva   Darvas Zsuzsanna   Falus Andras  

Acta Oncologica, Vol. 47, Iss. 3, 2007-07 ,pp. : 458-461

Informa Healthcare

Access to resources Recommend Favorite

Sjogren's Syndrome and Multiple Myeloma

By Rodriguez-Cuartero A.   Salas-Galan A.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 167-168

Elsevier

Access to resources Recommend Favorite